CIRM Funded Clinical Trials
Reduced intensity conditioning with JSP191 prior to TCRαβ+ T-cell/CD19+ B-cell depleted hematopoietic stem cell transplant for Fanconi Anemia patients
Disease Area:
Anemia
Trial Sponsor:
Stanford University
Trial Stage:
Phase 1/2
Trial Status:
Launching
Targeted Enrollment:
N/A
